Results
Eiko Lifesciences Q1 FY27 Net Profit Rises 54% YoY
Eiko Lifesciences Board approved unaudited standalone and consolidated financial results for Q1 FY27 ending June 30, 2026.
Standalone net profit increased to ₹106.44 lakhs with revenue of ₹1,417.81 la
